SavedAdd your journal

Journals / Türkderm Türk deri hastalıkları ve frengi arşivi / 2021 / Cilt: 55 - Sayı: 3

Island pedicle advancement flap: An effective technique for the repair of nasolabial defects

Leyla HUSEYNOVA
Gonca ELÇİN
Pages
153–155
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

HUSEYNOVA, L., ELÇİN, G. (2021). Island pedicle advancement flap: An effective technique for the repair of nasolabial defects. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 55 - Sayı: 3, 153–155. https://ajindex.com/articles/402208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Griffithsm CE, Barkers JN: Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263-71
  2. Van de Kerkhof PCM, Nestlé FO: Psoriasis. In: Bolognia JL, Jorizzo JJ, Cerroni L, editor. Dermatology (Forth edition) London: Elsevier; 2017:138-60
  3. Bawcock AM, Barker JN: Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol 2003;49(Suppl2):51-6
  4. Ni C, Chiu MW: Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol 2014;7:119-32
  5. Onumah N, Kircik LH: Psoriasis and its comorbidities. J Drugs Dermatol 2012;11(Suppl5):5-10
  6. Grieb G, Merk M, Bernhagen J, Bucala R: Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 2010;23:257-64
  7. Shimizu T: Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci 2005;37:65-73
  8. Steinhoff M, Meinhardt A, Steinhoff A, Gemsa D, Bucala R, Bacher M: Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease. Br J Dermatol 1999;141:1061-6
  9. Shimizu T, Nishihira J, Mizue Y, et al: Macrophage Migration Inhibitory Factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 2001;116:989-90
  10. Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, et al: Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis. Int J Clin Exp Med 2014;7:2605-14
  11. De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA, et al: Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. Hum Immunol 2014;75:433-9
  12. Donn RP, Plant D, Jury F, et al: Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004;123:484- 87
  13. Wu J, Chen F, Zhang X, et al: Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China. J Dermatol Sci 2009;53:212-5
  14. Eder L, Chandran V, Ueng J, et al: Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford) 2010;49:1367- 73
  15. Zhan Y, Wang YP, Li C, Liu SG, Gao Q: Association between single nucleotide polymorphism of macrophage migration inhibitory factor-rs1007888 and the pathogenesis of gestational diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi 2013;48:326-9
  16. Coban N, Onat A, Yildirim O, Can G, Erginel-Unaltuna N: Oxidative stressm